Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Evaluation of the expression levels of BRAFV600E mRNA in primary tumors of thyroid cancer using an ultrasensitive mutation assay

Fig. 3

Detection of BRAFV600E mutation in mRNA from clinical FFPE samples. BRAFV600E mRNA based mutation assay was utilized for ultrasensitive detection of the BRAFV600E mutation in mRNA isolated from clinical FFPE specimens of thyroid cancer and non-malignant thyroid disease. a Amplification signals from a sample containing mutant BRAFV600E mRNA (B7020 - red line), a sample without mutant BRAFV600E mRNA (B6659 - blue line) and no-template control (NTC - green line); b Corresponding melting peaks of the amplification products

Back to article page
\